FY2026 Earnings
Financial report interval: 2025.03.31 - 2026.03.31
Overview: Virax Biolabs(VRAX) the Revenue is 12.42 K (+96.21%), Beat estimate;the EBIT is -6.4 M (-3.84%), Miss estimate;the EPS is -12.64 (+68.79%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B96.21%
0.00B36.81%
+0.00B133.02%
EBITMiss expectations
-0.01B3.84%
-0.01B15.88%
-0.00B19.72%
EPSMiss expectations
-12.6468.79%
-1075.31%
-2.64006.52%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf